Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRC | P12931 | 1/20 | 0.59 |
| ▸ | STAT3 | P40763 | 1/20 | 0.51 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.48 |
| ▸ | ACHE | P22303 | 1/20 | 0.43 |
| ▸ | MSR1 | P21757 | 1/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.38 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.36 |
| ▸ | GRIA4 | P48058 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL309480 | 1.00 | SRC (0.59) | SRCSTAT3PTPN1ACHEMSR1 | |
| SCHEMBL156333 | 1.00 | SRC (0.59) | SRCSTAT3PTPN1ACHEMSR1 | |
| SCHEMBL5718782 | 0.91 | SRC (0.55) | SRCSTAT3PTPN1ALOX15ALDH1A1 | |
| SCHEMBL5718784 | 0.91 | SRC (0.55) | SRCSTAT3PTPN1ALOX15ALDH1A1 | |
| SCHEMBL1834290 | 0.84 | SRC (0.48) | SRCSTAT3PTPN1ACHEMSR1 | |
| SCHEMBL29558348 | 0.84 | SRC (0.48) | SRCSTAT3PTPN1ACHEMSR1 | |
| SCHEMBL17785039 | 0.84 | SRC (0.48) | SRCSTAT3PTPN1ACHEMSR1 | |
| SCHEMBL12500490 | 0.84 | SRC (0.48) | SRCSTAT3PTPN1ACHEMSR1 | |
| SCHEMBL30091075 | 0.84 | SRC (0.48) | SRCSTAT3PTPN1ACHEMSR1 | |
| SCHEMBL17785040 | 0.84 | SRC (0.48) | SRCSTAT3PTPN1ACHEMSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 182 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12446586-B2 | Oil-based insecticidal and insect repellent compositions | S. C. JOHNSON & SON, INC. (US) | 2025-10-21 | — | — | US | claimed |
| US-20250243302-A1 | FREE RADICAL ETHYLENE/TERPENE COPOLYMERS | BRASKEM S.A. (BR) | 2025-07-31 | — | — | US | claimed |
| WO-2025129179-A1 | FREE RADICAL ETHYLENE/TERPENE COPOLYMERS | BRASKEM S.A. (BR) | 2025-06-19 | — | — | WO | claimed |
| CN-117580477-A | Reducing viral infection | 福克斯生物有限公司 | 2024-02-20 | — | — | CN | claimed |
| US-20240050512-A1 | REDUCTION OF VIRAL INFECTIONS | PHOXBIO LIMITED (IE) | 2024-02-15 | — | — | US | claimed |
| US-20230397613-A1 | OIL-BASED INSECTICIDAL AND INSECT REPELLENT COMPOSITIONS | JOHNSON & SON INC S C (US) | 2023-12-14 | — | — | US | claimed |
| EP-4250991-A1 | REDUCTION OF VIRAL INFECTIONS | Phoxbio Limited (IE) | 2023-10-04 | — | — | EP | claimed |
| CN-116710123-A | Cytokine release and inhibition of cytokine storm | 萨恩帕斯药物有限公司 | 2023-09-05 | — | — | CN | claimed |
| EP-4229639-A1 | METHOD AND SYSTEMS FOR PHYTOMEDICINE ANALYTICS FOR RESEARCH OPTIMIZATION AT SCALE | GBS Global Biopharma, Inc. (CA) | 2023-08-23 | — | — | EP | claimed |
| WO-2022112430-A1 | REDUCTION OF VIRAL INFECTIONS | PHOXBIO LIMITED (IE) | 2022-06-02 | — | — | WO | claimed |
| US-20160090555-A1 | CLEANING AND/OR TREATMENT COMPOSITIONS COMPRISING MALODOR REDUCTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY | 2016-03-31 | — | — | US | claimed |
| US-20160089317-A1 | ANTIPERSPIRANT AND DEODORANT COMPOSITIONS COMPRISING MALODOR REDUCTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY | 2016-03-31 | — | — | US | claimed |
| WO-2016049455-A1 | PERSONAL CARE COMPOSITIONS COMPRISING MALODOR REDUCTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2016-03-31 | — | — | WO | claimed |
| WO-2016049458-A1 | DELIVERY SYSTEMS COMPRISING MALODOR REDUCTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2016-03-31 | — | — | WO | claimed |
| WO-2016049407-A1 | ABSORBENT ARTICLE COMPRISING MALODOR REDUCTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2016-03-31 | — | — | WO | claimed |
| WO-2016049395-A1 | PRODUCTS COMPRISING MALODOR REDUCTION MATERIALS | THE PROCTER & GAMBLE COMPANY (US) | 2016-03-31 | — | — | WO | claimed |
| WO-2016049404-A1 | SUBSTRATES COMPRISING MALODOR REDUCTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2016-03-31 | — | — | WO | claimed |
| US-20160090556-A1 | PRODUCTS COMPRISING MALODOR REDUCTION MATERIALS | THE PROCTER & GAMBLE COMPANY | 2016-03-31 | — | — | US | claimed |
| WO-2016049394-A1 | CLEANING AND/OR TREATMENT COMPOSITIONS COMPRISING MALODOR REDUCTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2016-03-31 | — | — | WO | claimed |
| WO-2016049396-A1 | ANTIPERSPIRANT AND DEODORANT COMPOSITIONS COMPRISING MALODOR REDUCTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2016-03-31 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160089317-A1 | ANTIPERSPIRANT AND DEODORANT COMPOSITIONS COMPRISING MALODOR REDUCTION COMPOSITIONS | LPO, QDPR, TYR | SRC 4268/4885STAT3 4690/4885PTPN1 253/4885 |
| US-20240050512-A1 | REDUCTION OF VIRAL INFECTIONS | TFRC, ZFR, HAMP | SRC 1923/4885STAT3 479/4885PTPN1 4496/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.